3D PET/CT wins accolades
The ability to simultaneously display 3D anatomic and molecular information to evaluate lung cancer earned recognition from the Society of Nuclear Medicine in its choice of image of the year.
The ability to simultaneously display 3D anatomic and molecular information to evaluate lung cancer earned recognition from the Society of Nuclear Medicine in its choice of image of the year.
Dr. Henry Wagner, who has performed this ritual for decades, singled out an example of 3D FDG-PET/CT bronchoscopy produced by Dr. Andrew Quon, an assistant professor of radiology at the Institute for Molecular Imaging at Stanford University.
The image displays a 3D primary lung lesion and an avid mediastinal lymph node partially obscured by the bronchus. Three-D-rendered multislice CT contributes a stunning view of surrounding anatomy and allows the physician to rule out endobronchial involvement.
The Stanford researcher stretched volume imaging and produced an exquisite structural and biochemical image, said Wagner, a professor of environmental health sciences at Johns Hopkins University and past president of the SNM.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
